Connor, Clark & Lunn Investment Management (CC&L)
AGN

Connor, Clark & Lunn Investment Management (CC&L)’s Allergan plc AGN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-41,650
Closed -$7.38M – 1249
2020
Q1 		$7.38M Sell
41,650
-1,125
-3% -$212K 0.07% 202
2019
Q4 		$8.18M Buy
42,775
+2,000
+5% +$361K 0.06% 205
2019
Q3 		$6.86M Sell
40,775
-80,284
-66% -$13.1M 0.05% 220
2019
Q2 		$20.3M Buy
121,059
+69,500
+135% +$9.62M 0.13% 122
2019
Q1 		$7.55M Buy
+51,559
New +$7.48M 0.05% 220
2018
Q4 		– Sell
-6,825
Closed -$1.3M – 1098
2018
Q3 		$1.3M Sell
6,825
-18,675
-73% -$3.43M 0.01% 528
2018
Q2 		$4.25M Sell
25,500
-23,500
-48% -$3.77M 0.02% 332
2018
Q1 		$8.25M Sell
49,000
-152,850
-76% -$25.6M 0.05% 226
2017
Q4 		$33M Buy
201,850
+90,525
+81% +$16.2M 0.19% 95
2017
Q3 		$22.8M Buy
111,325
+61,350
+123% +$14.3M 0.14% 120
2017
Q2 		$12.1M Buy
+49,975
New +$11.7M 0.08% 164
2016
Q3 		– Sell
-20,350
Closed -$4.7M – 946
2016
Q2 		$4.7M Buy
20,350
+10,400
+105% +$2.4M 0.03% 247
2016
Q1 		$2.67M Buy
+9,950
New +$2.85M 0.02% 301
2015
Q3 		– Sell
-26,547
Closed -$8.06M – 812
2015
Q2 		$8.06M Sell
26,547
-4,500
-14% -$1.34M 0.07% 120
2015
Q1 		$9.24M Sell
31,047
-7,200
-19% -$2.05M 0.08% 117
2014
Q4 		$9.85M Sell
38,247
-17,800
-32% -$4.45M 0.08% 109
2014
Q3 		$13.5M Buy
56,047
+12,300
+28% +$2.75M 0.11% 91
2014
Q2 		$10.4M Sell
43,747
-7,700
-15% -$1.59M 0.07% 116
2014
Q1 		$11.7M Buy
51,447
+30,600
+147% +$6.06M 0.09% 104
2013
Q4 		$3.72M Buy
+20,847
New +$3.26M 0.03% 183
2013
Q3 		– Sell
-28,100
Closed -$3.74M – 604
2013
Q2 		$3.74M Buy
+28,100
New +$3.18M 0.04% 130

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s AGN Position: Q2 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 41,650 shares — an estimated $7.38M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AGN in Q2 2013 and held it in 21 quarters. The position peaked at $33M in Q4 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 41,650 Allergan plc shares in Q2 2020, an estimated $7.38M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Allergan plc in Q2 2013 and held it in 21 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Allergan plc position peaked at $33M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2020, filed 13 Aug 2020.